Van Hulzen Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.12M | Buy |
6,025
+1,575
| +35% | +$561K | 0.16% | 96 |
|
|
2025
Q4 | $1.46M | Buy |
4,450
+219
| +5% | +$69.5K | 0.11% | 128 |
|
|
2025
Q3 | $1.19M | Sell |
4,231
-7,394
| -64% | -$2.14M | 0.09% | 143 |
|
|
2025
Q2 | $3.25M | Buy |
11,625
+142
| +1% | +$40.2K | 0.27% | 71 |
|
|
2025
Q1 | $3.58M | Sell |
11,483
-287
| -2% | -$84.8K | 0.33% | 67 |
|
|
2024
Q4 | $3.07M | Sell |
11,770
-198
| -2% | -$58.7K | 0.22% | 83 |
|
|
2024
Q3 | $3.86M | Buy |
11,968
+108
| +0.9% | +$35.3K | 0.28% | 75 |
|
|
2024
Q2 | $3.71M | Sell |
11,860
-1,899
| -14% | -$558K | 0.25% | 70 |
|
|
2024
Q1 | $3.91M | Buy |
13,759
+264
| +2% | +$77.2K | 0.26% | 74 |
|
|
2023
Q4 | $3.89M | Buy |
13,495
+102
| +0.8% | +$27.8K | 0.27% | 71 |
|
|
2023
Q3 | $3.6M | Sell |
13,393
-1,833
| -12% | -$457K | 0.28% | 72 |
|
|
2023
Q2 | $3.38M | Sell |
15,226
-51,221
| -77% | -$11.9M | 0.29% | 71 |
|
|
2023
Q1 | $16M | Buy |
66,447
+17,453
| +36% | +$4.28M | 1.51% | 22 |
|
|
2022
Q4 | $12.8M | Buy |
48,994
+11,662
| +31% | +$3.13M | 1.48% | 19 |
|
|
2022
Q3 | $8.41M | Buy |
37,332
+27,249
| +270% | +$6.61M | 1.04% | 29 |
|
|
2022
Q2 | $2.45M | Buy |
10,083
+105
| +1% | +$25.7K | 0.29% | 76 |
|
|
2022
Q1 | $2.41M | Sell |
9,978
-8,515
| -46% | -$1.96M | 0.26% | 78 |
|
|
2021
Q4 | $4.16M | Buy |
18,493
+328
| +2% | +$69.2K | 0.45% | 60 |
|
|
2021
Q3 | $3.86M | Buy |
18,165
+236
| +1% | +$54.3K | 0.57% | 50 |
|
|
2021
Q2 | $4.37M | Buy |
17,929
+1
| +0% | +$246 | 0.66% | 46 |
|
|
2021
Q1 | $4.46M | Sell |
17,928
-4,412
| -20% | -$1.05M | 0.71% | 47 |
|
|
2020
Q4 | $5.14M | Sell |
22,340
-37
| -0.2% | -$8.53K | 0.78% | 41 |
|
|
2020
Q3 | $5.69M | Sell |
22,377
-302
| -1% | -$74.8K | 0.86% | 37 |
|
|
2020
Q2 | $5.35M | Sell |
22,679
-867
| -4% | -$198K | 0.8% | 40 |
|
|
2020
Q1 | $4.77M | Buy |
23,546
+5,466
| +30% | +$1.19M | 1.03% | 31 |
|
|
2019
Q4 | $4.36M | Buy |
18,080
+6,227
| +53% | +$1.37M | 0.84% | 38 |
|
|
2019
Q3 | $2.29M | Buy |
11,853
+8,193
| +224% | +$1.57M | 0.48% | 48 |
|
|
2019
Q2 | $674K | Buy |
3,660
+961
| +36% | +$172K | 0.15% | 104 |
|
|
2019
Q1 | $513K | Sell |
2,699
-200
| -7% | -$38.2K | 0.14% | 108 |
|
|
2018
Q4 | $564K | Sell |
2,899
-77
| -3% | -$15K | 0.16% | 96 |
|
|
2018
Q3 | $617K | Buy |
2,976
+740
| +33% | +$146K | 0.16% | 103 |
|
|
2018
Q2 | $413K | Sell |
2,236
-1,672
| -43% | -$296K | 0.12% | 116 |
|
|
2018
Q1 | $666K | Sell |
3,908
-2,878
| -42% | -$528K | 0.2% | 94 |
|
|
2017
Q4 | $1.18M | Buy |
6,786
+2,500
| +58% | +$442K | 0.36% | 68 |
|
|
2017
Q3 | $799K | Buy |
4,286
+2,186
| +104% | +$387K | 0.27% | 83 |
|
|
2017
Q2 | $362K | Buy |
+2,100
| New | +$342K | 0.14% | 92 |
|
|
2015
Q4 | – | Sell |
-1,507
| Closed | -$208K | – | 146 |
|
|
2015
Q3 | $208K | Buy |
+1,507
| New | +$238K | 0.13% | 100 |
|
Other funds holding AMGN
VCM
VPM
Van Hulzen Asset Management's AMGN Position: Q1 2026 in Review
Van Hulzen Asset Management increased its Amgen (AMGN) stake by 35% in Q1 2026, buying an estimated $561K and bringing the position to 6,025 shares worth $2.12M. The position accounts for 0.16% of the portfolio, ranked #96.
Van Hulzen Asset Management first reported a position in AMGN in Q3 2015 and has held it in 37 quarters since. The position peaked at $16M in Q1 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Van Hulzen Asset Management held 6,025 shares of Amgen worth $2.12M as of Q1 2026.
- Van Hulzen Asset Management bought 1,575 Amgen shares in Q1 2026, an estimated $561K.
- Amgen made up 0.16% of Van Hulzen Asset Management's portfolio in Q1 2026, its #96 holding.
- Van Hulzen Asset Management first reported a position in Amgen in Q3 2015 and has held it in 37 quarters since.
- Van Hulzen Asset Management's Amgen position peaked at $16M in Q1 2023.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Van Hulzen Asset Management's 13F filing for Q1 2026, filed 14 May 2026.